No abstract available
MeSH terms
-
Adolescent
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Celecoxib / therapeutic use*
-
Child
-
Cyclooxygenase 2 / metabolism
-
Fibromatosis, Aggressive / diagnosis
-
Fibromatosis, Aggressive / drug therapy*
-
Humans
-
Magnetic Resonance Imaging
-
Male
-
Protein Kinase Inhibitors / therapeutic use
-
Receptors, Platelet-Derived Growth Factor / metabolism
-
Risk Factors
-
Sorafenib / therapeutic use*
-
Treatment Outcome
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Protein Kinase Inhibitors
-
Sorafenib
-
Cyclooxygenase 2
-
Receptors, Platelet-Derived Growth Factor
-
Celecoxib